Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BNT153 |
| Synonyms | |
| Therapy Description |
BNT153 consists of an mRNA for IL-2 contained within a lipid nanoparticle, which activates IL2Rb-dependent signaling, potentially resulting in increased antitumor response and tumor cell killing (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BNT153 | BNT-153|BNT 153 | BNT153 consists of an mRNA for IL-2 contained within a lipid nanoparticle, which activates IL2Rb-dependent signaling, potentially resulting in increased antitumor response and tumor cell killing (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04710043 | Phase I | BNT152 BNT153 | Dose Escalation Trial of BNT152+153 in Patients With Cancer | Completed | USA | CZE | 0 |